注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
主要投資於全球製藥、生物科技、保健服務、醫療技術及生命科學之企業(「醫療保健企業」),以期達到基金之回報目標。 子基金之資產(不包括現金及與現金相當之財產)至少67%將投資於醫療保健企業之權益證券。此等證券之發行人可位於任何國家,包括新興市場。 可輔助持有債權證券、現金及約當現金。 子基金可投資於可轉讓證券集體投資計畫及其他集體投資計畫。 子基金可投資於任何貨幣之資產,且子基金之貨幣曝險可進行避險或參考基金指標進行管理。 子基金可為避險目的及有效管理投資組合而投資於衍生性金融工具。
名稱 | 主旨 | 成立於 | 直至 |
---|---|---|---|
Dominic Valder | - | 2022 | now |
Holly Fleiss | - | 2022 | now |
自傳 | Ms. Fleiss is a Managing Director at JPMIM and a co-portfolio manager in the JPMorgan U.S. Equity Group. She has been with the firm since 2012. | ||
Matthew G. Cohen | Managing Director | 2015 | now |
自傳 | Matthew G. Cohen, M.D., managing director, is a research analyst in the U.S. Equity Group. An employee since 2005, Dr. Cohen has been portfolio manager since 2015 and a research analyst in the firm’s U.S. Equity Group since 2005. Before joining the firm, Matthew was a senior healthcare analyst at Medici Healthcare and a senior analyst covering medical products at Narragansett Asset Management, a New York-based healthcare hedge fund. Prior to that, Dr. Cohen was a resident surgeon in the Department of General Surgery at the North Shore University Hospital NYU School of Medicine. Matthew holds an M.B.A. from New York University Stern School of Business and an M.D. from McGill University in Montreal. | ||
Anne Marden | - | 2009 | now |
自傳 | Anne Marden, managing director, is a research analyst with the European Equity Research Team with responsibility for the pharmaceutical and healthcare sectors, and is co-portfolio manager of the Global Healthcare Fund. An employee since 1986, she obtained a B.A. in economics from Princeton and earned an M.B.A. from INSEAD. She is a holder of the CFA designation. | ||
Laurence McGrath | Executive Director | 2019 | 2022 |
自傳 | Laurence McGrath, executive director, is an analyst in Equity Research with over 20 years of industry experience. An employee since 2010, Laurence is responsible for analysing and investing in the U.S. Large Cap healthcare equipment and services sector. Before joining JPMorgan, he was a healthcare equipment and services analyst with Pioneer Investments. He holds a Bachelor of Commerce in banking and finance from the University College Dublin and a M.Sc. in investment and treasury management from Dublin City University. | ||
Premal Pajwani | - | 2014 | 2017 |
Scott Braunstein | Portfolio Manager, Research Analyst | 2009 | 2014 |
自傳 | Scott Braunstein is a portfolio manager and research analyst of pharmaceuticals and medical technology stocks and is a co-analyst of the Analyst Portfolio Strategy of JPMIM since July, 2004. Prior to joining JPMIM, he worked from 2000 to 2002 at Deutsche Bank Alex Brown and from 1999 to 2000 as Director of Operations for Defined Health. | ||
Management Team | - | 2011 | 2013 |
自傳 | Team Managed |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核